BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 28566173)

  • 1. Vitamin D
    Rolf L; Muris AH; Bol Y; Damoiseaux J; Smolders J; Hupperts R
    J Neurol Sci; 2017 Jul; 378():30-35. PubMed ID: 28566173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune regulatory effects of high dose vitamin D
    Muris AH; Smolders J; Rolf L; Thewissen M; Hupperts R; Damoiseaux J;
    J Neuroimmunol; 2016 Nov; 300():47-56. PubMed ID: 27806875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D
    Smolders J; Mimpen M; Oechtering J; Damoiseaux J; van den Ouweland J; Hupperts R; Kuhle J
    Acta Neurol Scand; 2020 Jan; 141(1):77-80. PubMed ID: 31657006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of vitamin D3 as add-on therapy in patients with relapsing-remitting multiple sclerosis receiving subcutaneous interferon β-1a: a Phase II, multicenter, double-blind, randomized, placebo-controlled trial.
    Smolders J; Hupperts R; Barkhof F; Grimaldi LM; Holmoy T; Killestein J; Rieckmann P; Schluep M; Vieth R; Hostalek U; Ghazi-Visser L; Beelke M;
    J Neurol Sci; 2011 Dec; 311(1-2):44-9. PubMed ID: 21620416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitamin D supplementation and systemic inflammation in relapsing-remitting multiple sclerosis.
    Røsjø E; Steffensen LH; Jørgensen L; Lindstrøm JC; Šaltytė Benth J; Michelsen AE; Aukrust P; Ueland T; Kampman MT; Torkildsen Ø; Holmøy T
    J Neurol; 2015 Dec; 262(12):2713-21. PubMed ID: 26429571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial.
    Okereke OI; Reynolds CF; Mischoulon D; Chang G; Vyas CM; Cook NR; Weinberg A; Bubes V; Copeland T; Friedenberg G; Lee IM; Buring JE; Manson JE
    JAMA; 2020 Aug; 324(5):471-480. PubMed ID: 32749491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial.
    Kampman MT; Steffensen LH; Mellgren SI; Jørgensen L
    Mult Scler; 2012 Aug; 18(8):1144-51. PubMed ID: 22354743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and T cell modulating effects of high dose vitamin D3 supplementation in multiple sclerosis.
    Smolders J; Peelen E; Thewissen M; Cohen Tervaert JW; Menheere P; Hupperts R; Damoiseaux J
    PLoS One; 2010 Dec; 5(12):e15235. PubMed ID: 21179201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of vitamin D supplementation on melatonin status in patients with multiple sclerosis.
    Golan D; Staun-Ram E; Glass-Marmor L; Lavi I; Rozenberg O; Dishon S; Barak M; Ish-Shalom S; Miller A
    Brain Behav Immun; 2013 Aug; 32():180-5. PubMed ID: 23665342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D3 administration to MS patients leads to increased serum levels of latency activated peptide (LAP) of TGF-beta.
    Åivo J; Hänninen A; Ilonen J; Soilu-Hänninen M
    J Neuroimmunol; 2015 Mar; 280():12-5. PubMed ID: 25773149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effect of vitamin D3 in multiple sclerosis patients.
    Mosayebi G; Ghazavi A; Ghasami K; Jand Y; Kokhaei P
    Immunol Invest; 2011; 40(6):627-39. PubMed ID: 21542721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of vitamin D supplementation in multiple sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial.
    Dörr J; Ohlraun S; Skarabis H; Paul F
    Trials; 2012 Feb; 13():15. PubMed ID: 22316314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D deficiency in patients with myasthenia gravis and improvement of fatigue after supplementation of vitamin D3: a pilot study.
    Askmark H; Haggård L; Nygren I; Punga AR
    Eur J Neurol; 2012 Dec; 19(12):1554-60. PubMed ID: 22672742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of High-Dose Supplementation With Oral Vitamin D3 on Depressive Symptoms in Dialysis Patients With Vitamin D3 Insufficiency: A Prospective, Randomized, Double-Blind Study.
    Wang Y; Liu Y; Lian Y; Li N; Liu H; Li G
    J Clin Psychopharmacol; 2016 Jun; 36(3):229-35. PubMed ID: 27022679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventive effect of vitamin D3 supplementation on conversion of optic neuritis to clinically definite multiple sclerosis: a double blind, randomized, placebo-controlled pilot clinical trial.
    Derakhshandi H; Etemadifar M; Feizi A; Abtahi SH; Minagar A; Abtahi MA; Abtahi ZA; Dehghani A; Sajjadi S; Tabrizi N
    Acta Neurol Belg; 2013 Sep; 113(3):257-63. PubMed ID: 23250818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin D Supplementation and Mental Health in Multiple Sclerosis Patients: A Systematic Review.
    Głąbska D; Kołota A; Lachowicz K; Skolmowska D; Stachoń M; Guzek D
    Nutrients; 2021 Nov; 13(12):. PubMed ID: 34959758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Vitamin A Supplementation on fatigue and depression in Multiple Sclerosis patients: A Double-Blind Placebo-Controlled Clinical Trial.
    Bitarafan S; Saboor-Yaraghi A; Sahraian MA; Soltani D; Nafissi S; Togha M; Beladi Moghadam N; Roostaei T; Mohammadzadeh Honarvar N; Harirchian MH
    Iran J Allergy Asthma Immunol; 2016 Feb; 15(1):13-9. PubMed ID: 26996107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short-term effect of high-dose vitamin D on the level of interleukin 10 in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled clinical trial.
    Ashtari F; Toghianifar N; Zarkesh-Esfahani SH; Mansourian M
    Neuroimmunomodulation; 2015; 22(6):400-4. PubMed ID: 26401986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon beta-1 a and depression in relapsing-remitting multiple sclerosis: an analysis of depression data from the PRISMS clinical trial.
    Patten SB; Metz LM
    Mult Scler; 2001 Aug; 7(4):243-8. PubMed ID: 11548984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of retinyl-palmitate on the level of pro and anti-inflammatory cytokines in multiple sclerosis patients: A randomized double blind clinical trial.
    Bitarafan S; Mohammadpour Z; Jafarirad S; Harirchian MH; Yekaninejad MS; Saboor-Yaraghi AA
    Clin Neurol Neurosurg; 2019 Feb; 177():101-105. PubMed ID: 30640138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.